BENJAMIN DONALDSON: Open Payments
NPI 1679835276 · LELAND, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 54 payments from 16 companies in 2025. Trend: 2023 $1,563 · 2024 $1,934 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $235 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Axsome Therapeutics, Inc. | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Janssen Pharmaceuticals, Inc | 4 | $76 |
| ABBVIE INC. | 4 | $70 |
| Neos Therapeutics, LP | 3 | $59 |
| Bausch Health US, LLC | 3 | $57 |
| Almatica Pharma LLC | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
Products named: HETLIOZ, REXULTI, CAPLYTA, Auvelity, SPRAVATO, VRAYLAR, Adzenys XR-ODT, APLENZIN.
Industry payments across NC — which companies pay providers there.
